Latest & greatest articles for endometriosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on endometriosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on endometriosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for endometriosis

121. Laparoscopic helium plasma coagulation of endometriosis

Laparoscopic helium plasma coagulation of endometriosis Laparoscopic helium plasma coagulation of endometriosis Laparoscopic helium plasma coagulation of endometriosis National Institute for Clinical Excellence Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation National Institute for Clinical Excellence. Laparoscopic helium plasma coagulation of endometriosis (...) . London: National Institute for Clinical Excellence (NICE) 2004: 2 Authors' objectives This study aims to assess the current evidence on the safety and efficacy of laparoscopic helium plasma coagulation of endometriosis. Authors' conclusions 1.1 Current evidence on the safety and efficacy of laparoscopic helium plasma coagulation of endometriosis does not appear adequate for this procedure to be used without special arrangements for consent and for audit or research. 1.2 Clinicians wishing

2004 Health Technology Assessment (HTA) Database.

122. Peritoneal fluid, endometriosis, and ciliary beat frequency in the human fallopian tube. (PubMed)

Peritoneal fluid, endometriosis, and ciliary beat frequency in the human fallopian tube. Endometriosis and infertility are known to be associated, but it is unclear whether endometriosis causes infertility. We used contrast analogue enhancement to study the effect of peritoneal fluid from women with early stage endometriosis on the ciliary beat frequency of human fallopian tube epithelium. We obtained peritoneal fluid from six women with early stage endometriosis and from six fertile women (...) with no evidence of endometriosis to use as controls. Fallopian tubes from hysterectomy specimens were collected from 17 women. The difference in ciliary beat frequency between fallopian tubes exposed to peritoneal fluids of women with and without endometriosis increased with the duration of incubation (mean difference at 24 h 1.35 Hz, 95% CI 0.94-1.75, p=0.01). At 24 h, ciliary beat frequency was significantly lower in the incubations with peritoneal fluid from women with endometriosis than controls (4.29

2002 Lancet

123. A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis

A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2002 DARE.

124. [Treatment of pain caused by endometriosis]

[Treatment of pain caused by endometriosis] Endometrioosin aiheuttaman kivun hoito [Treatment of pain caused by endometriosis] Endometrioosin aiheuttaman kivun hoito [Treatment of pain caused by endometriosis] Setala M, Hurskainen R, Kauko M, Kujansuu E, Tiitinen A, Vuorma S, Makela M Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Setala (...) M, Hurskainen R, Kauko M, Kujansuu E, Tiitinen A, Vuorma S, Makela M. Endometrioosin aiheuttaman kivun hoito. [Treatment of pain caused by endometriosis] Helsinki: Finnish Office for Health Care Technology Assessment (FinOHTA). FinOHTA Report No. 19. 2001 Authors' objectives This report aims to collect present knowledge on treating endometriosis-linked pain. Authors' conclusions NSAIDs decrease menstrual pain linked to endometriosis. Among hormonal drugs, a continuous peroral daily dose of 100

2001 Health Technology Assessment (HTA) Database.

125. Laparoscopic ablation or resection of endometriosis deposits for moderate and severe endometriosis

Laparoscopic ablation or resection of endometriosis deposits for moderate and severe endometriosis Laparoscopic ablation or resection of endometriosis deposits for moderate and severe endometriosis Laparoscopic ablation or resection of endometriosis deposits for moderate and severe endometriosis Ball C M Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Ball C M (...) . Laparoscopic ablation or resection of endometriosis deposits for moderate and severe endometriosis. London: Bazian Ltd (Editors), Wessex Institute for Health Research and Development, University of Southampton 2001: 9 Authors' objectives This study aims to assess the effects of laparoscopic ablation or resection of endometriosis deposits in women with moderate and severe endometriosis. Authors' conclusions Further studies are required to assess the role of laparoscopic surgery for managing stage III-IV

2001 Health Technology Assessment (HTA) Database.

126. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. (PubMed)

Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Endometriosis is a common gynaecological condition that frequently presents with the symptom of pain. The precise pathogenesis (mode of development) of endometriosis is unclear but it is evident that endometriosis arises by the dissemination of endometrium to ectopic sites and the subsequent establishment of deposits of ectopic endometrium. The observation that endometriosis is rarely seen in the hypo-oestrogenic (...) stimulation of the ovary).To determine the effectiveness of Gonadotrophin Releasing Hormone analogues (GnRHas) in the treatment of the painful symptoms of endometriosis by comparing them with no treatment, placebo, other recognised medical treatments, and surgical interventions.The search strategy of the Menstrual Disorders and Subfertility review group (please see Review Group details) was used to identify all randomised trials of the use of GnRHas for the treatment of the painful symptoms

2000 Cochrane

127. Danazol for pelvic pain associated with endometriosis. (Full text)

Danazol for pelvic pain associated with endometriosis. Endometriosis is defined as the presence of endometrial tissue (stromal and glandular) outside the normal uterine cavity. Conventional medical and surgical treatments for endometriosis aim to remove or decrease deposits of ectopic endometrium. The observation that hyperandrogenic states (an excess of male hormone) induce atrophy of the endometrium has led to the use of androgens in the treatment of endometriosis. Danazol is one (...) of these treatments used. The efficacy of danazol is based on its ability to produce a high androgen/low estrogen environment (a pseudo menopause) which results in the atrophy of endometriotic implants and thus an improvement in painful symptoms.To determine the effectiveness of danazol compared to placebo or no treatment in the treatment of the symptoms and signs, other than infertility, of endometriosis in women of reproductive age.The Menstrual Disorders Group search strategy was used to identify randomised

2000 Cochrane PubMed

128. An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: placebo-controlled studies

An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: placebo-controlled studies An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: placebo-controlled studies An evidence-based medicine approach to the treatment of endometriosis-associated chronic pelvic pain: placebo-controlled studies Howard F M Authors' objectives To assess the efficacy of treatment of endometriosis-associated chronic pelvic (...) pain. Searching MEDLINE was searched from 1976 to 1998 for articles published in the English language, using a combination of the following MeSH and textwords: 'endometriosis', 'pelvic pain', 'treatment'. Additional studies were located by examining the references from the identified studies, and by contacting the authors of selected studies. Study selection Study designs of evaluations included in the review Placebo-controlled randomised clinical trials (RCTs) were eligible if they scored at least

2000 DARE.

129. Is minimal or mild endometriosis associated with infertility?

Is minimal or mild endometriosis associated with infertility? Is minimal or mild endometriosis associated with infertility? Is minimal or mild endometriosis associated with infertility? Burrows E Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Burrows E. Is minimal or mild endometriosis associated with infertility? Clayton, Victoria: Centre for Clinical (...) Effectiveness (CCE) 2000: 16 Authors' objectives This aim of this report was to assess whether minimal or mild endometriosis is associated with infertility. Authors' conclusions - Six studies met the inclusion/exclusion criteria - The best evidence available does not confirm an association between minimal and mild endometriosis and infertility. However, a consistent trend in results suggests a negative impact of minimal and mild endometriosis on fertility. - Four of the six identified studies were conducted

2000 Health Technology Assessment (HTA) Database.

130. Surgical management of endometriosis

Surgical management of endometriosis Surgical management of endometriosis Surgical management of endometriosis Vercellini P, De Giorgi O, Pisacreta A, Pesole A P, Vicentini S, Crosignani P G Authors' objectives To evaluate the effects of pelvic denervations in addition to conservative surgery on dysmenorrhoea and deep dyspareunia associated with endometriosis. Searching Articles published in the English language were sought in MEDLINE (1977 to 1998) and EMBASE (1980 to 1998) using the following (...) MeSH terms: 'endometriosis', 'pelvic pain', 'presacral neurectomy', 'uterosacral ligament resection' and 'surgical therapy'. Handsearches were conducted of the main specialty journals (American Journal of Obstetrics and Gynaecology, British Journal of Obstetrics and Gynaecology, Fertility and Sterility, and Obstetrics and Gynaecology). Additional reports were identified by reviewing all references from retrieved articles and by consulting books and monographs on endometriosis published in the last

2000 DARE.

131. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis

The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis Mol B W, Bayram N, Lijmer J G, Wiegerinck M A, Bongers M Y, van der Veen F, Bossuyt P M Authors' objectives To assess the diagnostic performance of serum CA-125 measurement in the detection of endometriosis. Searching MEDLINE (from (...) January 1966 to November 1997) and EMBASE (from January 1988 to November 1997) were searched using the keywords `CA125' or `CA-125', `laparoscopy' and all phrases containing the word `endometriosis'. Cross-references in selected articles were checked. Study selection Study designs of evaluations included in the review Diagnostic cohort and case-control studies were eligible for inclusion. Specific interventions included in the review Articles reporting serum CA-125 measurement were eligible

1998 DARE.

132. The evidence for the management of endometriosis

The evidence for the management of endometriosis The evidence for the management of endometriosis The evidence for the management of endometriosis Farquhar C, Sutton C Authors' objectives To summarise the effectiveness and safety of medical and surgical management of endometriosis. Searching The search strategy of the Cochrane Menstrual Disorders and Subfertility Group was used to identify trials on MEDLINE and EMBASE (years not stated). The database of the Cochrane Menstrual Disorders (...) and Subfertility Group was also available to the authors. Thirty key journals were handsearched and the reference lists of other RCTs were also searched. Unpublished studies were identified from abstracts and conference proceedings, and from pharmaceutical companies. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) which compared an ovulatory suppressive agent in the treatment of endometriosis-associated pain with placebo; compared other ovulatory

1998 DARE.

133. Human issues and medical economics of endometriosis: three- vs. six-month GnRH-agonist therapy

Human issues and medical economics of endometriosis: three- vs. six-month GnRH-agonist therapy Human issues and medical economics of endometriosis: three- vs. six-month GnRH-agonist therapy Human issues and medical economics of endometriosis: three- vs. six-month GnRH-agonist therapy Heinrichs W L, Henzl M R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of a short-term course of intranasal gonadotropin-releasing hormone agonist (GnRH-a) as both a diagnostic tool and a treatment in women with symptoms of endometriosis. Type of intervention Diagnosis and treatment. Economic study type Cost-effectiveness analysis. Study population Women with the symptoms of endometriosis, in particular chronic pelvic pain. Setting

1998 NHS Economic Evaluation Database.

134. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. (PubMed)

Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. Minimal or mild endometriosis is frequently diagnosed in infertile women. It is often treated by resection or ablation of the lesions, but whether this improves fertility has not been established. We carried out a randomized, controlled trial to determine whether laparoscopic surgery enhanced fecundity in infertile women with minimal or mild endometriosis.We studied 341 (...) infertile women 20 to 39 years of age with minimal or mild endometriosis. During diagnostic laparoscopy the women were randomly assigned to undergo resection or ablation of visible endometriosis or diagnostic laparoscopy only. They were followed for 36 weeks after the laparoscopy or, for those who became pregnant during that interval, for up to 20 weeks of pregnancy.Among the 172 women who had resection or ablation of endometriosis, 50 became pregnant and had pregnancies that continued for 20 weeks

1997 NEJM

135. Progestins for symptomatic endometriosis: a critical analysis of the evidence

Progestins for symptomatic endometriosis: a critical analysis of the evidence Progestins for symptomatic endometriosis: a critical analysis of the evidence Progestins for symptomatic endometriosis: a critical analysis of the evidence Vercellini P, Cortesi I, Crosignani P G Authors' objectives To obtain estimates of the effectiveness of progestin treatment for pelvic pain associated with endometriosis. Searching MEDLINE was searched from 1966 to 1996 for studies published in the English language (...) , using the MeSH terms 'endometriosis', 'pelvic pain', 'dysmenorrhea', 'dyspareunia', 'infertility' and 'medical therapy'. In addition, selected speciality journals and Current Contents (Clinical Medicine) were handsearched (January 1976 to June 1996 and January 1986 to June 1996, respectively). References from retrieved articles, and from books and monographs on endometriosis published in the previous 10 years, were examined for additional studies. Study selection Study designs of evaluations

1997 DARE.

136. Pelvic endometriosis: impact of magnetic resonance imaging on treatment decisions and costs

Pelvic endometriosis: impact of magnetic resonance imaging on treatment decisions and costs Pelvic endometriosis: impact of magnetic resonance imaging on treatment decisions and costs Pelvic endometriosis: impact of magnetic resonance imaging on treatment decisions and costs Sugimura K, Imaoka I, Okizuka H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Magnetic resonance imaging for patients with diagnosed pelvic endometriosis. Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis. Study population Patients (aged 24-48 years, mean=36 years) with clinically suspected endometriosis. Setting Hospital. The economic study was carried out in Izumo, Japan. Dates to which data relate The main effectiveness

1996 NHS Economic Evaluation Database.

137. Using economics alongside medical audit: a case study of the management of endometriosis

Using economics alongside medical audit: a case study of the management of endometriosis Using economics alongside medical audit: a case study of the management of endometriosis Using economics alongside medical audit: a case study of the management of endometriosis Bodner C, Vale L, Ratcliffe J, Farrar S Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Expectant treatment, andmedical treatment in the management of patients with newly diagnosed endometriosis associated infertility were compared. Type of intervention Treatment. Economic study type Cost-effectiveness analysis and cost-utility analyses. Study population Patients with newly diagnosed endometriosis associated infertility. Setting Hospital. The economic study

1996 NHS Economic Evaluation Database.

138. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. (PubMed)

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. Treatment with nafarelin, a gonadotropin-releasing hormone agonist, reversibly inhibits ovarian function and induces hypoestrogenemia. To determine the efficacy of such hormonal manipulation in the treatment of endometriosis, we randomly assigned 213 patients with laparoscopically confirmed endometriosis to receive, for six months, either nafarelin by nasal (...) to 11.7 with 400 micrograms of nafarelin, and from 18.4 to 10.5 with danazol (P = 0.0001 within each group; there were no statistically significant differences between the groups). The percentage of women with severely painful symptoms of endometriosis decreased from about 40 percent to 5 to 10 percent, whereas the percentage with no or minimal discomfort rose from 25 to 70 percent. Of the 149 patients who tried to become pregnant, 58 (39 percent) succeeded after the completion of treatment; similar

1988 NEJM